Skip to content

Clinical trials

Medulloblastoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Country / region: Australia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20042
20073
20081
20101
20111
20133
20172
20181
20191
20202
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting7
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group9
National Cancer Institute (NCI)9
Novartis Pharmaceuticals2
Bristol-Myers Squibb1
Cellectar Biosciences, Inc.1
Donald Mabbott1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
NYU Langone Health1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma28
Neuroblastoma12
Central Nervous System Neoplasms10
Glioma10
Ependymoma9
Osteosarcoma9
Astrocytoma8
Rhabdomyosarcoma8
Sarcoma8
Neuroectodermal Tumors, Primitive, Peripheral7

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.